Patents by Inventor Todd P. Glancy

Todd P. Glancy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200277622
    Abstract: The subject invention relates in part to the surprising discovery that Cry1Da is active against corn earworm (CEW), Helicoverpa zea (Boddie). Methods for using Cry1Da in transgenic plants to prevent serious crop damage is described. Leaf and silk bioassays using transgenic maize expressing full length, core toxin region or chimeric Cry1Da demonstrated good insect protection against CEW larvae damage.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Applicant: AGRIGENETICS, INC.
    Inventors: SEK YEE TAN, JOEL J SHEETS, TODD P GLANCY, AARON TODD WOOSLEY, SARAH E WORDEN, DIAA ALABED, STEPHANIE LOVE BURTON, KAREN C MCLAUGHLIN, KENNETH NARVA, THOMAS MEADE
  • Publication number: 20200248197
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 6, 2020
    Applicant: Dow AgroSciences LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Pahao Wang, Todd P. Glancy, Shreedharan Sriram, Carla N. Yerkes, Andrew J. Bowling, Heather Pence, Andrew E. Robinson
  • Publication number: 20200184403
    Abstract: Engineered and modified Cry6Aa insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed.
    Type: Application
    Filed: February 24, 2020
    Publication date: June 11, 2020
    Applicant: DOW AGROSCIENCES LLC
    Inventors: TIMOTHY D HEY, XIAOPING XU, TODD P GLANCY, DIAA ALABED, SARAH E WORDEN, XUELIN WANG, CARLA AUSMUS, SHAO-CHING HUNG
  • Publication number: 20200157154
    Abstract: The subject invention concerns Bacillus thuringiensis modified Cry1Ca insecticidal toxins and the polynucleotide sequences which encode these toxins. Uses in transgenic plants are described as are methods for protecting crops from insect pest damage.
    Type: Application
    Filed: February 3, 2020
    Publication date: May 21, 2020
    Applicant: DOW AGROSCIENCES LLC
    Inventors: JOEL J SHEETS, KENNETH NARVA, THOMAS MEADE, TIMOTHY D HEY, SEK YEE TAN, AUDREY JANE ETTER, TODD P GLANCY, JANNA MAI ARMSTRONG, TRISTAN E CORAM, KRISHNA M MADDURI, JAMES E KING, RYAN M LEE, GAOFENG LIN, JIANQUAN LI
  • Patent number: 10612036
    Abstract: Engineered and modified Cry6Aa insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: April 7, 2020
    Assignee: DOW AGROSCIENCES LLC
    Inventors: Timothy D. Hey, Xu Xiaoping, Todd P. Glancy, Diaa Alabed, Sarah E. Worden, Nick X. Wang, Carla Ausmus, Shao-Ching Hung
  • Patent number: 10570182
    Abstract: The subject invention concerns Bacillus thuringiensis modified Cry1Ca insecticidal toxins and the polynucleotide sequences which encode these toxins. Uses in transgenic plants are described as are methods for protecting crops from insect pest damage.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: February 25, 2020
    Assignee: DOW AGROSCIENCES LLC
    Inventors: Joel J. Sheets, Kenneth Narva, Thomas Meade, Timothy D. Hey, Sek Yee Tan, Audrey Jane Etter, Todd P. Glancy, Janna Mai Armstrong, Tristan E. Coram, Krishna M. Madduri, James E. King, Ryan M. Lee, Gaofeng Lin, Jianquan Li
  • Publication number: 20180100162
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
    Type: Application
    Filed: September 15, 2017
    Publication date: April 12, 2018
    Applicant: Dow AgroSciences LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Pohao Wang, Todd P. Glancy, Shreedharan Sriram, Carla N. Yerkes, Andrew J. Bowling, Heather Pence, Andrew E. Robinson
  • Publication number: 20170369539
    Abstract: The subject invention concerns Bacillus thuringiensis modified Cry1Ca insecticidal toxins and the polynucleotide sequences which encode these toxins. Uses in transgenic plants are described as are methods for protecting crops from insect pest damage.
    Type: Application
    Filed: December 16, 2015
    Publication date: December 28, 2017
    Applicant: Dow Agrosciences LLC
    Inventors: Joel J. SHEETS, Kenneth NARVA, Thomas MEADE, Timothy D. HEY, Sek Yee TAN, Audrey Jane ETTER, Todd P. GLANCY, Janna Mai ARMSTRONG, Tristan E. CORAM, Krishna M. MADDURI, James E. KING, Ryan M. LEE, Gaofeng LIN, Jianquan LI
  • Patent number: 9738705
    Abstract: Described herein are murine monoclonal antibodies and methods useful for determining and quantitating the presence of Cry1Ca delta endotoxin. The claimed antibodies specifically bind the core toxin region making them suitable for detecting the native full length Cry1Ca toxin as well as the amino core toxin and N-terminal 29 residue truncated forms.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: August 22, 2017
    Assignee: Dow AgroSciences LLC
    Inventors: Eric Hongzheng Ma, Guomin Shan, Todd P. Glancy, Sarah E. Canada
  • Publication number: 20170051304
    Abstract: Engineered and modified Cry6Aa insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed.
    Type: Application
    Filed: August 10, 2016
    Publication date: February 23, 2017
    Inventors: Timothy D. Hey, Xu Xiaoping, Todd P. Glancy, Diaa Alabed, Sarah E. Worden, Nick X. Wang, Carla Ausmus, Shao-Ching Hung
  • Publication number: 20150309027
    Abstract: Described herein are murine monoclonal antibodies and methods useful for determining and quantitating the presence of Cry1Ca delta endotoxin. The claimed antibodies specifically bind the core toxin region making them suitable for detecting the native full length Cry1Ca toxin as well as the amino core toxin and N-terminal 29 residue truncated forms.
    Type: Application
    Filed: April 23, 2015
    Publication date: October 29, 2015
    Inventors: Eric Hongzheng Ma, Guomin Shan, Todd P. Glancy, Sarah E. Canada
  • Patent number: 8003777
    Abstract: The present invention provides methods, vectors and gene constructs for enhancing expression of a recombinant nucleic acid sequence in transgenic plants and plant tissues. According to the present invention, nucleic acid sequences are obtained and/or derived from the 5? and 3? untranslated regions of genes encoding osmotin proteins and engineered to flank respective portions of a selected coding region of a vector. The vector construct may be introduced into plants and/or plant tissues through conventional procedures, resulting in enhanced expression of the selected coding region. In a preferred embodiment, the selected coding region is a chimeric gene or gene fragment expressing one or more proteins known to impart a level of insecticidal activity to a transgenic plant and/or plant tissue.
    Type: Grant
    Filed: February 5, 2008
    Date of Patent: August 23, 2011
    Assignee: Dow AgroSciences LLC
    Inventors: Donald J. Merlo, Dong Liu, Stephanie L. Burton, Todd P. Glancy
  • Patent number: 7122205
    Abstract: Methods for tissue repair are provided employing a matrix comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0.01 to about 500 mg/mL at about 25° C. and adhesive strength of about 600 to about 150,000 Pa and applying the matrix to a tissue defect. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.
    Type: Grant
    Filed: March 29, 2004
    Date of Patent: October 17, 2006
    Assignee: DePuy Products, Inc.
    Inventors: Dale R. Peterson, Z. David Deng, Todd P. Glancy
  • Patent number: 6923985
    Abstract: Improved matrices and adhesives for tissue repair comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0.01 to about 500 mg/mL at about 25° C. and adhesive strength of about 600 to about 150,000 Pa. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: August 2, 2005
    Assignee: DePuy Orthopaedics, Inc.
    Inventors: Dale R. Peterson, Z. David Deng, Todd P. Glancy
  • Publication number: 20040180074
    Abstract: Methods for tissue repair are provided employing a matrix comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0.01 to about 500 mg/mL at about 25° C. and adhesive strength of about 600 to about 150,000 Pa and applying the matrix to a tissue defect. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.
    Type: Application
    Filed: March 29, 2004
    Publication date: September 16, 2004
    Inventors: Dale R. Peterson, Z. David Deng, Todd P. Glancy
  • Patent number: 6733787
    Abstract: Methods for tissue repair are provided employing a matrix comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0.01 to about 500 mg/mL at about 25° C. and adhesive strength of about 600 to about 150,000 Pa and applying the matrix to a tissue defect. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: May 11, 2004
    Assignee: DePuy Orthopaedics, Inc.
    Inventors: Dale R. Peterson, Z. David Deng, Todd P. Glancy
  • Patent number: 6458763
    Abstract: The present invention is directed to bioactive compositions that induce the repair of damaged or diseased connective tissues upon contact of the damaged or diseased tissues with the composition in vivo. More particularly the present invention is directed to the use of compositions comprising an effective amount of bone sialoprotein to enhance the repair of damaged or diseased bone.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: October 1, 2002
    Assignee: DePuy Orthopeadics
    Inventors: Dale R. Peterson, Nancy Nousek-Goebl, Todd P. Glancy
  • Publication number: 20020034533
    Abstract: Methods for tissue repair are provided employing a matrix comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0.01 to about 500 mg/mL at about 25° C. and adhesive strength of about 600 to about 150,000 Pa and applying the matrix to a tissue defect. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.
    Type: Application
    Filed: September 19, 2001
    Publication date: March 21, 2002
    Inventors: Dale R. Peterson, Z. David Deng, Todd P. Glancy
  • Publication number: 20020031551
    Abstract: Improved matrices and adhesives for tissue repair comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0.01 to about 500 mg/mL at about 25° C. and adhesive strength of about 600 to about 150,000 Pa. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.
    Type: Application
    Filed: August 6, 2001
    Publication date: March 14, 2002
    Inventors: Dale R. Peterson, Z. David Deng, Todd P. Glancy
  • Patent number: 6326025
    Abstract: The present invention is directed to a biocompatible tissue reactive composition comprising a functionalized polymer having tissue reactive substituents that are capable of forming covalent bonds with tissue associated functional groups.
    Type: Grant
    Filed: April 24, 2000
    Date of Patent: December 4, 2001
    Assignee: DePuy Orthopaedics, Inc
    Inventors: Gerry Sigler, Z. David Deng, Dale R. Peterson, Todd P. Glancy, Samuel I. Stupp